Breaking News Instant updates and real-time market news.

RVNC

Revance

$33.65

-1.1 (-3.17%)

08:39
12/07/17
12/07
08:39
12/07/17
08:39

Revance 5.4M share Secondary priced at $31.00

The deal size was lowered to $150M in common stock from $175M in common stock. Goldman Sachs and Cowen acted as joint book running managers for the offering.

  • 07

    Dec

RVNC Revance
$33.65

-1.1 (-3.17%)

12/05/17
PIPR
12/05/17
NO CHANGE
Target $51
PIPR
Overweight
Piper ups Revance price target to $51 on 'impressive' data
Piper Jaffray analyst David Amsellem raised his price target for Revance Therapeutics (RVNC) to $51 from $28 saying this morning's Phase III results for RT002 are "impressive." The stock in afternoon trading is up 38%, or $10.00, to $36.00. The company can now credibly claim that its "frown lines" treatment confers "significant benefit" for a sizable group of patients out to six months, Amsellem tells investors in an intraday research note. He thinks RT002 could offer the potential not only for less frequent procedures compared to Allergan's (AGN) Botox but also the potential for better treatment outcomes. Allergan in afternoon trading is down $2.13 to $164.72. The analyst believes the question now for RT002 is not approvability, but rather what a differentiated label would look like. Amsellem also feels the data "should embolden" Revance to "cast a wider net in terms of the pursuit of additional indications." He reiterates an Overweight rating on the shares.
12/05/17
GUGG
12/05/17
INITIATION
Target $42
GUGG
Buy
Revance initiated with a Buy at Guggenheim
Guggenheim analyst Rohit Vanjani initiated Revance with a Buy and $42 price target.
12/05/17
WELS
12/05/17
NO CHANGE
WELS
Outperform
Allergan selloff on Revance data overdone, says Wells Fargo
Wells Fargo analyst David Maris views the selloff today in shares of Allergan (AGN) following Revance Therapeutics' (RVNC) frown lines data as overdone. While the positive Phase III results are good news for Revance, the data are yet to be seen in detail and it is unclear how significant a competitor RT002 could be to Allergan's Botox, Maris tells investors in a post-close research note. The analyst says that while RT002 showed statistically significant results at week 24 versus placebo in a key secondary endpoint, the measurement of this endpoint does not seem to match the FDA's published draft guidance. As such, it is unclear if the data will be enough to get a six-month duration claim on the RT002 label, Maris argues. The analyst keeps an Outperform rating on Allergan shares, which closed the trading day down $2.62 to $164.28.
12/06/17
MSCO
12/06/17
NO CHANGE
MSCO
Overweight
Morgan Stanley maintains Botox sales projections after Revance drug data
While Morgan Stanley analyst David Risinger said Revance (RVNC) presented "compelling" Phase 3 investigator-assessed responder rates for RT002 compared to Allergan's (AGN) Botox, he contends that patient-assessed rates, which look much closer in comparison, may be more reflective of potential uptake. Risinger, who believes aesthetics market retreatment decisions will mainly be determined by patients, maintains his Botox sales projections and Overweight rating on Allergan after yesterday's report of data from its competitor.

TODAY'S FREE FLY STORIES

AU

AngloGold

$7.15

-0.015 (-0.21%)

13:30
08/17/18
08/17
13:30
08/17/18
13:30
Options
AngloGold Ashanti attracts an earnings hedge »

AngloGold Ashanti…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:30
08/17/18
08/17
13:30
08/17/18
13:30
General news
NY Fed's GDP Nowcast model shows a 2.39% rate of growth for Q2 »

NY Fed's GDP Nowcast…

XOP

SPDR Oil Exploration and Production Fund

$39.57

0.08 (0.20%)

13:20
08/17/18
08/17
13:20
08/17/18
13:20
Options
Notable volatility play in SPDR Oil Exploration and Production ETF options »

Notable volatility play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
08/17/18
08/17
13:17
08/17/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
08/17/18
08/17
13:16
08/17/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
08/17/18
08/17
13:15
08/17/18
13:15
General news
FOMC minutes to the June 30, August 1 policy meeting »

FOMC minutes to the June…

13:05
08/17/18
08/17
13:05
08/17/18
13:05
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 8/17 Baker-Hughes…

ZOES

Zoe's Kitchen

$12.80

3.275 (34.40%)

13:02
08/17/18
08/17
13:02
08/17/18
13:02
Downgrade
Zoe's Kitchen rating change  »

Zoe's Kitchen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

BHGE

Baker Hughes

$31.02

-0.57 (-1.80%)

13:02
08/17/18
08/17
13:02
08/17/18
13:02
Hot Stocks
Baker Hughes reports U.S. rig count unchanged at 1,057 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZOES

Zoe's Kitchen

$12.80

3.275 (34.40%)

13:01
08/17/18
08/17
13:01
08/17/18
13:01
Downgrade
Zoe's Kitchen rating change  »

Zoe's Kitchen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

ATGE

Adtalem Global Education

$47.20

-8.5 (-15.26%)

12:46
08/17/18
08/17
12:46
08/17/18
12:46
Recommendations
Adtalem Global Education analyst commentary  »

Adtalem Global Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

12:45
08/17/18
08/17
12:45
08/17/18
12:45
General news
Breaking General news story  »

Week of 8/17 Baker-Hughes…

SPY

SPDR S&P 500 ETF Trust

$284.47

0.38 (0.13%)

, XLF

Financial Select Sector

$28.12

0.02 (0.07%)

12:43
08/17/18
08/17
12:43
08/17/18
12:43
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week redemptions…

SPY

SPDR S&P 500 ETF Trust

$284.47

0.38 (0.13%)

XLF

Financial Select Sector

$28.12

0.02 (0.07%)

XLU

Utilities SPDR

$54.50

0.25 (0.46%)

VT

Vanguard Total World Stock ETF

$74.55

0.175 (0.24%)

GLD

SPDR Gold Trust

$111.57

0.46 (0.41%)

VOO

Vanguard S&P 500 ETF

$261.36

0.34 (0.13%)

IVV

iShares Core S&P 500

$286.46

0.34 (0.12%)

SPLV

Powershares S&P 500 Low Volatility Portfolio

$49.79

0.23 (0.46%)

SSO

ProShares Ultra S&P 500

$121.69

0.34 (0.28%)

XLP

Consumer Staples Sector SPDR

$55.01

0.38 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$141.08

0.44 (0.31%)

12:40
08/17/18
08/17
12:40
08/17/18
12:40
Options
Opening activity in Visa expiring puts »

Opening activity in Visa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 12

    Sep

ANET

Arista Networks

$269.22

1.35 (0.50%)

, AAPL

Apple

$216.51

3.02 (1.41%)

12:38
08/17/18
08/17
12:38
08/17/18
12:38
Recommendations
Arista Networks, Apple analyst commentary  »

Arista Networks products…

ANET

Arista Networks

$269.22

1.35 (0.50%)

AAPL

Apple

$216.51

3.02 (1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 04

    Sep

SYNL

Synalloy

$23.10

0.2 (0.87%)

12:33
08/17/18
08/17
12:33
08/17/18
12:33
Hot Stocks
Synalloy's Bristol Metals awarded $8M tubing order »

Synalloy is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

12:30
08/17/18
08/17
12:30
08/17/18
12:30
General news
U.S. Data Slate - Week of August 20: »

U.S. Data Slate - Week of…

CWT

California Water Service

$40.90

0.25 (0.62%)

, SJW

SJW Corp.

$66.74

0.2 (0.30%)

12:27
08/17/18
08/17
12:27
08/17/18
12:27
Hot Stocks
California Water Service withdraws $70 per share offer to buy SJW Corp. »

California Water Service…

CWT

California Water Service

$40.90

0.25 (0.62%)

SJW

SJW Corp.

$66.74

0.2 (0.30%)

CTWS

Connecticut Water

$68.23

0.15 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$52.99

-2.71 (-4.87%)

12:25
08/17/18
08/17
12:25
08/17/18
12:25
Options
Nutanix call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

12:22
08/17/18
08/17
12:22
08/17/18
12:22
Hot Stocks
Breaking Hot Stocks news story  »

Rosehill Resources Inc…

12:17
08/17/18
08/17
12:17
08/17/18
12:17
Hot Stocks
Breaking Hot Stocks news story  »

Rosehill Resources Inc…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
08/17/18
08/17
12:17
08/17/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
08/17/18
08/17
12:16
08/17/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFG

National Fuel

$57.05

0.47 (0.83%)

12:10
08/17/18
08/17
12:10
08/17/18
12:10
Options
Notable new position opened in National Fuel Gas options »

Notable new position…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$507.92

5.34 (1.06%)

12:06
08/17/18
08/17
12:06
08/17/18
12:06
Periodicals
Chipotle to require all workers to take quarterly food-safety test, BI reports »

Chipotle intends to start…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.